Joseph Alexander Pieprzyca, PA-C

Joseph Pieprzyca practices at USC Care Medical Group, Inc in Glendale, California.

Joseph Pieprzyca's NPI, 1114221389, was assigned on January 3, 2011. Joseph Pieprzyca holds California license PA20646.

Joseph Pieprzyca's primary practice is USC Care Medical Group, Inc, at 1808 Verdugo Blvd, Glendale, CA 91208 in Los Angeles County. The practice phone is (323) 442-5955.

Joseph Pieprzyca's primary practice is USC Care Medical Group, Inc in Glendale, California. Joseph Pieprzyca is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Joseph Pieprzyca to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joseph Pieprzyca practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Joseph Pieprzyca's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Joseph Pieprzyca is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Joseph Pieprzyca is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, UTI and yeast infection among the conditions Joseph Pieprzyca treats.

CMS data shows 1,125 Medicare services from Joseph Pieprzyca across 11 procedure codes in 2024, for 264 Medicare patients. Medicare paid $63,556 for them.

CMS counts 264 Medicare patients who saw Joseph Pieprzyca in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joseph Pieprzyca's median patient age at 72, with 22% women.

In 2024, Joseph Pieprzyca wrote 839 Medicare Part D claims for 238 patients. 81% of them were for generic drugs. CMS names the drug for 717 of them, across 16 drugs with 11 or more claims each, at $104,740 in total drug cost.

Joseph Pieprzyca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Joseph Pieprzyca as offering telehealth.

CMS Open Payments shows 72 general payments to Joseph Pieprzyca from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. Sumitomo Pharma America, Inc. paid the most, $412.